AOB

[shaker340]

Michael,
     Do you have an exit price in mind?  What are your thoughts for short and medium term?

[Michael]

Hi Shaker,

Thanks for the applauds!

I have to admit that I haven't really thought about exit. This stock is so undervalued so I think I am here for a long time. I will consider it at the next earnings.

Short time I can see some resistance at 3 but it should be able to go through it.

[la-onda]

agree with you Michael, still long with AOB


updated chart:

[shaker340]

Thanks for the reply Michael.  I'm with you on this one, I like the potential.

[Michael]

Hi Shaker and Oliver,
Nice to see that I am not alone on this long travel up to the north

It seems like AOB is poised to break out of the small base between 2.25 and 2.5. (if there is any TA guy's joining us on the journey I would appreciate your comments on the technical picture!)

[la-onda]

still holding AOB !!

BUYINS.NET: Naked Short Web Site Announces ANTP, AOB, ESMC, IW, LPL, NTES Have Been Removed From Threshold Lists Today
Monday , August 08, 2005 10:29 ET

American Oriental Bioengineering, Inc. (AMEX: AOB) engages in the development and production of bioengineer products and traditional Chinese medicinal products. The company's product line includes Health Food, Chinese Medical, and Soybean Protein Peptide products. Health Food product series include compound bio-functional beverage, a nutritional beverage; iodine bio-functional beverage, a compound bio-functional beverage with Iodine additives; and vitamate oral liquid, which is designed to strengthen the immue system. Chinese Medical products series include cease enuresis soft gel that helps alleviate bed-wetting and urination disorder; root of red-rooted salvia tablet that improves blood circulation to remove blood stasis; and double ginseng yishen grain, which is useful for those suffering from neurosis. Soybean protein peptide products include soybean protein peptide powder and soybean protein peptide coffee nutritious health drinks; and soybean protein peptide tablets, which maintains or improves protein nutrient condition of the human body. It offers its products through distributors, sales outlets, and hospital and clinics. The company markets its products in China, the United States, Europe, and Brazil. The company was founded as Champion Ventures, Inc. in 1970 and changed its name to Internet Golf Association, Inc. in 1999 as a result of its merger with Internet Golf Association, Inc. Further, the company changed its name to American Oriental Bioengineering, Inc. as per the terms of an agreement to acquire Harbin Three Bioengineering Limited. American Oriental Bioengineering is headquartered in Harbin, China. With 21.99 million shares in its float and an undisclosed short position, there is no longer a failure to deliver in shares of AOB.

[shaker340]

I'm still here also

[Michael]

Hi Shaker and Oliver,

Just a small stop to before the journey continue 

I think we are seeing the effect of AOB being removed from the naked short list. There are apparantly people that buy shares when they comes on the list and off load them when the stock is taken off again. As this doesn't change the fundamentals of the company I will ignore it!

[shaker340]

Hey Michael,
    Thanks for the insight, how much more of a drop should we expect? Today was brutal

[la-onda]

wasn´t a good day yesterday, hope it will bounce back

Unconfirmed Earnings Expected Monday, Aug 15
Thursday , August 11, 2005 06:50 ET

Based on historical evidence the following companies are expected to report their quarterly earnings on Monday, August 15, 2005. These companies have NOT confirmed these dates.

SYMBOL  COMPANY                                   PERIOD  WHEN   EST/REVENUE  EST/EPS
------  -------                                   ------  ----   -----------  -------

AOB     American Oriental Bioengineering Inc        Q2     BMO        $9.65M     0.05


updated chart:

[la-onda]

Record EARNINGS, above estimations !!!

American Oriental Bioengineering Reports Record 2005 Second Quarter Results
Monday August 15, 8:00 am ET
Revenue Increases 98.2% and Income From Operations Increases 140.9% Leading to 122.5% Increase in Net Income; Company Reports Quarterly Diluted EPS of 8 Cents

HONG KONG--(BUSINESS WIRE)--Aug. 15, 2005-- America Oriental Bioengineering, Inc. (AMEX: AOB - News), a rapidly growing Chinese company that produces and distributes a broad range of pharmaceutical and nutraceutical products, announced today record second quarter and six-month results for the period ended June 30, 2004. The Company generated 2005 second quarter revenue of $11.9 million, a 98.2% increase compared to $6.0 million for the same period in 2004. American Oriental Bioengineering generated Income from Operations of $4.4 million, a 140.9% increase from $1.9 million in the 2004 second quarter. The Company had net income of $3.4 million, or $0.08 per basic and diluted share, a 122.6% increase versus $1.5 million, or $0.05 per basic and diluted share, for the comparable period in 2004.
For the six months ended June 30, 2005, American Oriental Bioengineering Inc. had revenue of $21.6 million, an increase of 81% compared to $11.9 million for the same six-month period in 2004. The Company reported Income from Operations of $7.5 million, a 117.8% increase from the $3.4 million reported for the same period in fiscal 2004. American Oriental Bioengineering generated net income of $5.5 million, or $0.14 per basic share ($0.13 per diluted share), a 100% increase compared to $2.8 million, or $0.08 per basic and diluted share for the first six months of fiscal 2004.

The Company ended the period with its strongest balance sheet ever, as it had cash and cash equivalents at June 30, 2005 of $11.4 million compared to $5.4 million at the end of the first six months of 2004.

Second quarter sales of the Company's PBP Products increased by 223% as compared to the same period in 2004, contributing to American Oriental Bioengineering's strong results. This growth was primarily a result of an increase in sales of Cease Enuresis Soft Gel products. Also, the acquisition of HSPL contributed to the increase in sales of PBP Products due to a broader product line. Sales of PBN Products increased by 21%, as a result of increased marketing and sales initiatives.

"We continue to experience rapid growth as a result of our innovative products and expanded distribution capabilities," said Tony (Shujun) Liu, Chairman and Chief Executive Officer of American Oriental Bioengineering, Inc. "The acquisition of HSPL has enabled us to expand our product line and enter new markets. Through the combination of new product initiatives and expanded sales and marketing activities and a strong balance sheet, we believe we are well positioned to continue to generate strong organic growth and to selectively pursue accretive acquisitions."

awesome results, AOB will go much higher IMO
updated chart

[la-onda]

awesome results from AOB, check my updated post before:
AOB: Q2 Results 8c vs 5c; Beats 5c Est; No Guidance
Monday , August 15, 2005 08:03 ET

QUARTER RESULTS
American Oriental Bioengineering Inc (AOB) reported Q2 results ended June 2005. Q2 Revenues were $11.90M; +98.33% vs yr-ago; BEATING revenue consensus by +23.32%. Q2 EPS was 8c; +60.00% vs yr-ago; BEATING earnings consensus by +60.00%.

Q2 RESULTS      Reported      Year-Ago     Y/Y Chg      Estimate    SURPRISE
----------  ------------  ------------  ----------  ------------  ----------
Revenues:        $11.90M        $6.00M       +98.33%        $9.65M     +23.32%
----------  ------------  ------------  ----------  ------------  ----------
EPS:                  8c                5c            +60.00%            5c     +60.00%
----------  ------------  ------------  ----------  ------------  ----------

QUARTERLY GUIDANCE:
Company provided NO Revenue guidance for next quarter.

Company provided NO EPS guidance for next quarter.

ANNUAL GUIDANCE:
Company provided NO Revenue guidance for coming year.

Company provided NO EPS guidance for coming year.

[David Randolph]

I'll buy it back again at the open ! (let's see if I can buy lower than the sale at $2.48 a couple of weeks ago)

Buying AOB for the 3 Stocks on Fire Portfolio at the open, 6.66% of capital.

Thanks for the alert la-onda !

[rocket8]

my ameritrade screener shows no GAP up.  is there one?  if not, why not?
results are very good.

is there a GAP up price -- meaning a price beyond which you would not buy AOB ?
(perhaps it might make sense to provide that price on fast moving stocks)

-rocket8

[johandebroyer]

I just bought DDSI !!!

$0.01USD./DDSI this Week!